However, VEGF inhibitors have a higher and more severe side effect profile than DA and its DA-Ag, which can be accepted for certain cancer patients due to their critical situation but can certainly be improved for patients with endometriosis, OA, and some types of cancer [17,81]. This evidence concerns the gene VEGFA and cancer.